Compositions and methods for treating and preventing amyotrophic lateral sclerosis

MYPI2025004364A0Undetermined Publication Date: 2020-06-14BIOGEN MA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004364
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-04-30
Filing Date
2019-12-12
Publication Date
2020-06-14
Patent Text Reader

Abstract

Dosage regimens for SOD1-targeting antisense oligonucleotides, and salts thereof, are provided. These dosage regimens find use in the treatment of subjects having or at risk of developing amyotrophic lateral sclerosis. Figure 5.
Need to check novelty before this filing date? Find Prior Art